{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T17:58:13Z","timestamp":1768413493085,"version":"3.49.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"am","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AI145825"],"award-info":[{"award-number":["U19AI145825"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.tmrv.2023.150779","type":"journal-article","created":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T09:59:15Z","timestamp":1697363955000},"page":"150779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Current Insights Into K-associated Fetal Anemia and Potential Treatment Strategies for Sensitized Pregnancies"],"prefix":"10.1016","volume":"38","author":[{"given":"Margaret C.","family":"Carpenter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scarlett C.","family":"Souter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronnie J.","family":"Zipkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4253-3476","authenticated-orcid":false,"given":"Margaret E.","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2023.150779_bib0001","first-page":"548","article-title":"Neonatal outcomes of pregnancies affected by haemolytic disease of the foetus and newborn and managed with intrauterine transfusion: a service evaluation","volume":"11","author":"Birchenall","year":"2013","journal-title":"Blood Transfus"},{"issue":"2","key":"10.1016\/j.tmrv.2023.150779_bib0002","doi-asserted-by":"crossref","first-page":"100203","DOI":"10.1016\/j.xagr.2023.100203","article-title":"Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010","volume":"3","author":"Yu","year":"2023","journal-title":"AJOG Glob Rep"},{"key":"10.1016\/j.tmrv.2023.150779_bib0003","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/17474086.2017.1331124","article-title":"Neonatal management and outcome in alloimmune hemolytic disease","volume":"10","author":"Ree","year":"2017","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.tmrv.2023.150779_bib0004","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tmrv.2016.05.008","article-title":"Hemolytic disease of the fetus and newborn: modern practice and future investigations","volume":"30","author":"Hendrickson","year":"2016","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2023.150779_bib0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.tmrv.2018.07.002","article-title":"Red blood cell alloimmunization in the pregnant patient","volume":"32","author":"Webb","year":"2018","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2023.150779_bib0006","series-title":"National Center for Biotechnology Information","first-page":"81","article-title":"Blood Groups and Red Cell Antigens","author":"Dean","year":"2005"},{"key":"10.1016\/j.tmrv.2023.150779_bib0007","series-title":"The blood group antigen factsbook","author":"Reid","year":"2012"},{"key":"10.1016\/j.tmrv.2023.150779_bib0008","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12288-017-0792-1","article-title":"ABO hemolytic disease of fetus and newborn; still a diagnostic dilemma: a case report","volume":"34","author":"Kumawat","year":"2018","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.tmrv.2023.150779_bib0009","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0301-2115(00)00428-0","article-title":"Non-anti-D antibodies in red-cell alloimmunization","volume":"92","author":"Moise","year":"2000","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.tmrv.2023.150779_bib0010","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1056\/NEJM199803193381204","article-title":"Inhibition of erythroid progenitor cells by anti-kell antibodies in fetal alloimmune anemia","volume":"338","author":"Vaughan","year":"1998","journal-title":"NEJM"},{"key":"10.1016\/j.tmrv.2023.150779_bib0011","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0002-9378(96)70425-8","article-title":"Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia","volume":"174","author":"Weiner","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2023.150779_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2020.102949","article-title":"Three non-classical mechanisms for anemic disease of the fetus and newborn, based on maternal anti-Kell, anti-Ge3, anti-M, and anti-Jra cases","volume":"59","author":"Ohto","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tmrv.2023.150779_bib0013","doi-asserted-by":"crossref","first-page":"S600","DOI":"10.1016\/j.ajog.2020.12.993","article-title":"968 Estimation of hemolytic disease of the newborn in the United States from 1996-2010","volume":"224","author":"Ling","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2023.150779_bib0014","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0002-9378(86)90398-4","article-title":"Kell sensitization in pregnancy","volume":"154","author":"Caine","year":"1986","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2023.150779_bib0015","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1182\/blood.V85.4.912.bloodjournal854912","article-title":"Molecular Basis of the Kell (Kl) Phenotype","volume":"85","author":"Lee","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2023.150779_bib0016","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1053\/beha.1999.0045","article-title":"Kell, Kx and the McLeod syndrome","volume":"12","author":"Redman","year":"1999","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.tmrv.2023.150779_bib0017","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1537-2995.2005.04289.x","article-title":"Onset of expression of the components of the Kell blood group complex","volume":"45","author":"Pu","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150779_bib0018","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0002-9378(96)70161-8","article-title":"Prenatal diagnosis of Kell blood group genotypes: KEL1 and KEL2","volume":"175","author":"Lee","year":"1996","journal-title":"AJOG"},{"key":"10.1016\/j.tmrv.2023.150779_bib0019","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1537-2995.1996.36696269506.x","article-title":"Genotyping of KEL1 and KEL2 of the human Kell blood group system by the polymerase chain reaction with sequence-specific primers","volume":"36","author":"Hessner","year":"1996","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150779_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/985646","article-title":"IgG placental transfer in healthy and pathological pregnancies","volume":"2012","author":"Palmeira","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.tmrv.2023.150779_bib0021","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1728-4465.2014.00393.x","article-title":"Intended and unintended pregnancies worldwide in 2012 and recent trends","volume":"45","author":"Sedgh","year":"2014","journal-title":"Studies in family planning"},{"key":"10.1016\/j.tmrv.2023.150779_bib0022","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.0001-6349.2004.00394.x","article-title":"Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999","volume":"83","author":"van Kamp","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.tmrv.2023.150779_bib0023","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1537-2995.2003.00327.x","article-title":"Causes of fetal anemia in hemolytic disease due to\u2003anti-K","volume":"43","author":"Daniels","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150779_bib0024","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0002-9378(94)90477-4","article-title":"Erythropoietic suppression in fetal anemia because of Kell alloimmunization","volume":"171","author":"Vaughan","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2023.150779_bib0025","first-page":"239","article-title":"Maternal Kell blood group alloimmunization","volume":"79","author":"Bowman","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2023.150779_bib0026","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0140-6736(88)91896-X","article-title":"Fetal haemoglobin measurement in the assessment of red cell isoimmunisation","volume":"331","author":"Nicolaides","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.tmrv.2023.150779_bib0027","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200001063420102","article-title":"Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses","volume":"342","author":"Mari","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2023.150779_bib0028","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1056\/NEJMoa052855","article-title":"Doppler ultrasonography versus amniocentesis to predict fetal anemia","volume":"355","author":"Oepkes","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2023.150779_bib0029","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/uog.1821","article-title":"Non-invasive tests to predict fetal anemia in Kell-alloimmunized pregnancies","volume":"25","author":"van Dongen","year":"2005","journal-title":"Ultrasound in Obstet Gyn"},{"key":"10.1016\/j.tmrv.2023.150779_bib0030","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/01.AOG.0000260957.77090.4e","article-title":"Obstetric history and antibody titer in estimating severity of kell alloimmunization in pregnancy","volume":"109","author":"van Wamelen","year":"2007","journal-title":"Obstet Gyn"},{"key":"10.1016\/j.tmrv.2023.150779_bib0031","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1542\/neo.22-1-e7","article-title":"Update on the use of intravenous immunoglobulin in pregnancy","volume":"22","author":"D'Mello","year":"2021","journal-title":"NeoReviews"},{"key":"10.1016\/j.tmrv.2023.150779_bib0032","doi-asserted-by":"crossref","first-page":"e8747","DOI":"10.15252\/msb.20188747","article-title":"Antibody Fab-Fc properties outperform titer in predictive models of SIV vaccine-induced protection","volume":"15","author":"Pittala","year":"2019","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.tmrv.2023.150779_bib0033","series-title":"Fetal therapy: scientific basis and critical appraisal of clinical benefits","author":"Kilby","year":"2020"},{"key":"10.1016\/j.tmrv.2023.150779_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.earlhumdev.2021.105381","article-title":"School performance and behavioral functioning in children after intrauterine transfusions for hemolytic disease of the fetus and newborn","volume":"157","author":"Ree","year":"2021","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.tmrv.2023.150779_bib0035","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1182\/asheducation-2016.1.446","article-title":"Understanding red blood cell alloimmunization triggers","volume":"2016","author":"Hendrickson","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.tmrv.2023.150779_bib0036","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1159\/000368995","article-title":"Factors influencing RBC alloimmunization: lessons learned from murine models","volume":"41","author":"Ryder","year":"2014","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.tmrv.2023.150779_bib0037","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1182\/blood.2020009376","article-title":"Marginal zone B cells mediate a CD4 T-cell\u2013dependent extrafollicular antibody response following RBC transfusion in mice","volume":"138","author":"Zerra","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2023.150779_bib0038","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.3324\/haematol.2015.128603","article-title":"Anti-KEL sera prevents alloimmunization to transfused KEL RBCs in a murine model","volume":"100","author":"Stowell","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2023.150779_bib0039","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1182\/blood.2021011973","article-title":"\u201cAllo\u201d from the (marginal) zone","volume":"138","author":"Yazdanbakhsh","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2023.150779_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.704072","article-title":"Complement plays a critical role in inflammation-induced immunoprophylaxis failure in mice","volume":"12","author":"Escamilla-Rivera","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.tmrv.2023.150779_bib0041","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1182\/asheducation-2009.1.185","article-title":"Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn","volume":"2009","author":"Brinc","year":"2009","journal-title":"Hematology"},{"key":"10.1016\/j.tmrv.2023.150779_bib0042","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1084\/jem.11.2.241","article-title":"Active immunity produced by so called balanced or neutral mixtures of diphtheria toxin and antitoxin","volume":"11","author":"Smith","year":"1909","journal-title":"J Exp Med"},{"key":"10.1016\/j.tmrv.2023.150779_bib0043","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1111\/j.1537-2995.2006.00924_1.x","article-title":"On the immunologic basis of Rh immune globulin (anti-D) prophylaxis","volume":"46","author":"Kumpel","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150779_bib0044","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1537-2995.1971.tb04424.x","article-title":"Studies on Rh Prophylaxis","volume":"11","author":"Pollack","year":"1971","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150779_bib0045","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1073\/pnas.96.5.2244","article-title":"Efficient IgG-mediated suppression of primary antibody responses in Fc\u03b3 receptor-deficient mice","volume":"96","author":"Karlsson Mikael","year":"1999","journal-title":"PNAS"},{"key":"10.1016\/j.tmrv.2023.150779_bib0046","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.4049\/jimmunol.1302287","article-title":"Antibody-mediated immune suppression of erythrocyte alloimmunization can occur independently from red cell clearance or epitope masking in a murine model","volume":"193","author":"Yu","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2023.150779_sbref0047","series-title":"StatPearls [Internet]","article-title":"Rh Incompatibility. [Updated 2022 Dec 11]","author":"Costumbrado","year":"2023"},{"key":"10.1016\/j.tmrv.2023.150779_bib0048","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/vox.12265","article-title":"Haemolytic disease of the fetus and newborn","volume":"109","author":"de Haas","year":"2015","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2023.150779_bib0049","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/00003081-197106000-00021","article-title":"Rh immunization\u2013experience with full-term pregnancies","volume":"14","author":"Freda","year":"1971","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.tmrv.2023.150779_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2008.03735.x","article-title":"Lessons learnt from many years of experience using anti-D in humans for prevention of RhD immunization and haemolytic disease of the fetus and newborn","volume":"154","author":"Kumpel","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.tmrv.2023.150779_bib0051","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1111\/j.1537-2995.2008.01742.x","article-title":"One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy","volume":"48","author":"Koelewijn","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150779_bib0052","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/tme.12091","article-title":"BCSH guideline for the use of anti-D immunoglobulin for the prevention of hemolytic disease of the fetus and newborn","volume":"24","author":"Qureshi","year":"2014","journal-title":"Transfus Med"},{"key":"10.1016\/j.tmrv.2023.150779_bib0053","first-page":"40","article-title":"The multiple use of RhoGAM","volume":"65","author":"Keith","year":"1973","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.tmrv.2023.150779_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2020.102950","article-title":"RhIg for the prevention Rh immunization and IVIg for the treatment of affected neonates","volume":"59","author":"Legler","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tmrv.2023.150779_bib0055","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/j.1537-2995.2011.03480.x","article-title":"Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model","volume":"52","author":"Tiller","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150779_bib0056","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1471-2393-14-87","article-title":"Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHDgenotyping and a review of policy and practice","volume":"14","author":"Kent","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.tmrv.2023.150779_bib0057","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235807","article-title":"Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: a preventable disease that still produces significant morbidity and mortality in children","volume":"15","author":"Pegoraro","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.tmrv.2023.150779_bib0058","doi-asserted-by":"crossref","first-page":"315","DOI":"10.5468\/ogs.2020.63.3.315","article-title":"Recombinant anti-D for prevention of maternal-foetal Rh(D) alloimmunization: a randomized multi-centre clinical trial","volume":"63","author":"Mayekar","year":"2020","journal-title":"Obstet Gynecol Sci"},{"key":"10.1016\/j.tmrv.2023.150779_bib0059","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1423-0410.2007.00945.x","article-title":"Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti-D immunoglobulin: more questions than answers","volume":"93","author":"Kumpel","year":"2007","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2023.150779_bib0060","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1365-2141.2001.02701.x","article-title":"Guidelines for the clinical use of red cell transfusions","volume":"113","author":"Murphy","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2023.150779_bib0061","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1423-0410.1997.00045.x","article-title":"In vitro functional activity of IgG1 and IgG3 polyclonal and monoclonal anti-D","volume":"72","author":"Kumpel","year":"1997","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2023.150779_bib0062","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.tmrv.2023.150779_bib0063","first-page":"64","article-title":"Aggregates in blood filter chambers used from the plasma donations of anti-D donors: evaluation for monoclonal antibody discovery using phage display","volume":"19","author":"McGowan","year":"2021","journal-title":"Blood Transfus"},{"key":"10.1016\/j.tmrv.2023.150779_bib0064","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1172\/JCI65708","article-title":"Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity","volume":"123","author":"Ackerman","year":"2013","journal-title":"JCI"},{"key":"10.1016\/j.tmrv.2023.150779_bib0065","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0896-8411(91)90173-A","article-title":"Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy","volume":"4","author":"Rook","year":"1991","journal-title":"J Autoimmun"},{"key":"10.1016\/j.tmrv.2023.150779_bib0066","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/s41598-019-57393-9","article-title":"Anti-D monoclonal antibodies from 23 human and rodent cell lines display diverse IgG Fc-glycosylation profiles that determine their clinical efficacy","volume":"10","author":"Kumpel","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.tmrv.2023.150779_bib0067","doi-asserted-by":"crossref","first-page":"169","DOI":"10.12688\/f1000research.2-169.v1","article-title":"Anti-rhesus D prophylaxis in pregnant women is based on sialylated IgG antibodies","volume":"2","author":"Winkler","year":"2013","journal-title":"F1000Res"},{"key":"10.1016\/j.tmrv.2023.150779_bib0068","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/trf.12880","article-title":"Prophylactic anti-D preparations display variable decreases in Fc-fucosylation of anti-D","volume":"55","author":"Kapur","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150779_bib0069","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fimmu.2018.00129","article-title":"Fc-Glycosylation in human IgG1 and IgG3 Is Similar for both total and anti-red-blood cell anti-K antibodies","volume":"9","author":"Sonneveld","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.tmrv.2023.150779_bib0070","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/bjh.14438","article-title":"Antigen specificity determines anti-red blood cell IgG-Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn","volume":"176","author":"Sonneveld","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2023.150779_bib0071","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/bjh.12965","article-title":"Low anti-R h DI g G-F c-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn","volume":"166","author":"Kapur","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2023.150779_bib0072","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/bjh.14053","article-title":"Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia","volume":"174","author":"Sonneveld","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2023.150779_bib0073","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3389\/fimmu.2020.01516","article-title":"IgG subclass determines suppression versus enhancement of humoral alloimmunity to kell RBC antigens in mice","volume":"11","author":"Shinde","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.tmrv.2023.150779_bib0074","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1182\/bloodadvances.2019001299","article-title":"Passively transferred IgG enhances humoral immunity to a red blood cell alloantigen in mice","volume":"4","author":"Gruber","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.tmrv.2023.150779_bib0075","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.972723","article-title":"Fc\u03b3RIV is required for IgG2c mediated enhancement of RBC alloimmunization","volume":"13","author":"Qiu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.tmrv.2023.150779_bib0076","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.3389\/fimmu.2020.01393","article-title":"Fc gamma receptors and their role in antigen uptake, presentation, and T cell activation","volume":"11","author":"Junker","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.tmrv.2023.150779_bib0077","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1182\/blood.2022018591","article-title":"Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression","volume":"142","author":"Jajosky","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2023.150779_bib0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2020.102947","article-title":"Non-invasive prenatal testing for management of haemolytic disease of the fetus and newborn induced by maternal alloimmunisation","volume":"59","author":"Hyland","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tmrv.2023.150779_bib0079","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/bjh.17041","article-title":"Medical therapy to attenuate fetal anaemia in severe maternal red cell alloimmunisation","volume":"192","author":"Castleman","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2023.150779_bib0080","first-page":"171","article-title":"Maternal and neonatal tetanus elimination: from protecting women and newborns to protecting all","volume":"7","author":"Khan","year":"2015","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.tmrv.2023.150779_bib0081","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135375","article-title":"Severe Infections in HIV-Exposed Uninfected Infants Born in a European Country","volume":"10","author":"Adler","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.tmrv.2023.150779_bib0082","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0198-8859(00)00244-5","article-title":"Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells","volume":"62","author":"Antohe","year":"2001","journal-title":"Human Immunol"},{"key":"10.1016\/j.tmrv.2023.150779_bib0083","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.tmrv.2023.150779_bib0084","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.3389\/fimmu.2020.01920","article-title":"Update on transplacental transfer of IgG subclasses: impact of maternal and fetal factors","volume":"11","author":"Clements","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.tmrv.2023.150779_bib0085","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/trf.16341","article-title":"Targeting the neonatal Fc receptor (FcRn) to treat autoimmune diseases and maternal-fetal immune cytopenias","volume":"61","author":"Wyckoff","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150779_bib0086","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1182\/blood-2010-05-284919","article-title":"Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy","volume":"116","author":"Chen","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2023.150779_bib0087","doi-asserted-by":"crossref","first-page":"498.e1","DOI":"10.1016\/j.ajog.2019.02.058","article-title":"M281, an anti-FcRn antibody, inhibits IgG transfer in a human ex vivo placental perfusion model","volume":"220","author":"Roy","year":"2019","journal-title":"AJOG"},{"key":"10.1016\/j.tmrv.2023.150779_bib0088","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1172\/JCI57850","article-title":"The maternal immune response to fetal platelet GPIb\u03b1 causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies","volume":"121","author":"Li","year":"2011","journal-title":"J of Clinic Invest"},{"key":"10.1016\/j.tmrv.2023.150779_bib0089","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1182\/blood.V126.23.3472.3472","article-title":"M281: a therapeutic Anti-FcRn blocking antibody for rapid clearance of IgG and IgG autoantibodies in immune cytopenias and other auto\/allo-immune disease","volume":"126","author":"Ling","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2023.150779_bib0090","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.3389\/fimmu.2019.03052","article-title":"Antagonism of the neonatal Fc receptor as an emerging treatment for myasthenia gravis","volume":"10","author":"Gable","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.tmrv.2023.150779_bib0091","unstructured":"Johnson & Johnson. New Phase 2 data demonstrate potential benefit of Nipocalimab for pregnant individuals at high risk of early-onset severe hemolytic disease of the fetus and newborn (HDFN). PRNewswire: Cision, 2023."},{"key":"10.1016\/j.tmrv.2023.150779_bib0092","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1172\/JCI97911","article-title":"Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans","volume":"128","author":"Ulrichts","year":"2018","journal-title":"J Clinic Invest"},{"key":"10.1016\/j.tmrv.2023.150779_bib0093","doi-asserted-by":"crossref","first-page":"eaan1208","DOI":"10.1126\/scitranslmed.aan1208","article-title":"The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: a randomized phase 1 study","volume":"9","author":"Kiessling","year":"2017","journal-title":"Science Transl Med"},{"key":"10.1016\/j.tmrv.2023.150779_bib0094","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S1474-4422(21)00159-9","article-title":"Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial","volume":"20","author":"Howard","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.tmrv.2023.150779_bib0095","doi-asserted-by":"crossref","first-page":"e853","DOI":"10.1212\/WNL.0000000000011108","article-title":"Efficacy and Safety of Rozanolixizumab in moderate to severe generalized myasthenia gravis","volume":"96","author":"Bril","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.tmrv.2023.150779_bib0096","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1182\/blood-2020-140558","article-title":"Immunoadsorption, Intravenous Immunoglobulins and Rituximab (IIR): successful new treatment approach for severe anti K- alloimmunisation during pregnancy","volume":"136","author":"Capraru","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2023.150779_bib0097","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.1129594","article-title":"Anti-inflammatory activity of immunoglobulin G resulting from Fc Sialylation","volume":"313","author":"Kaneko","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.tmrv.2023.150779_bib0098","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature10134","article-title":"Intravenous Gammaglobulin suppresses inflammation through a novel TH2 pathway","volume":"475","author":"Anthony","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.tmrv.2023.150779_bib0099","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1537-2995.2010.02905.x","article-title":"Unexpected suppression of anti-Fya and prevention of hemolytic disease of the fetus and newborn after administration of Rh immune globulin","volume":"51","author":"Branch","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150779_bib0100","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1537-2995.2006.00898.x","article-title":"Antenatal administration of Rh-immune globulin causes significant increases in the immunomodulatory cytokines transforming growth factor-beta and prostaglandin E2","volume":"46","author":"Branch","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150779_bib0101","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/trf.12049","article-title":"NHLBI retrovirus epidemiology donor study-II. Does Rh immune globulin suppress HLA sensitization in pregnancy?","volume":"53","author":"Kaufman","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2023.150779_bib0102","doi-asserted-by":"crossref","first-page":"9995","DOI":"10.1038\/s41598-019-46484-2","article-title":"Human DC-SIGN and CD23 do not interact with human IgG","volume":"9","author":"Temming","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.tmrv.2023.150779_bib0103","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1471-2474-15-178","article-title":"The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease","volume":"15","author":"Marco","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.tmrv.2023.150779_bib0104","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1186\/ar2798","article-title":"Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response","volume":"11","author":"Nakou","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.tmrv.2023.150779_bib0105","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/SLA.0000000000002924","article-title":"IdeS (Imlifidase): a novel agent that cleaves human igg and permits successful kidney transplantation across high-strength donor-specific antibody","volume":"268","author":"Lonze","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.tmrv.2023.150779_bib0106","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1111\/ajt.14733","article-title":"Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients","volume":"18","author":"Lorant","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.tmrv.2023.150779_bib0107","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMoa1612567","article-title":"IgG Endopeptidase in highly sensitized patients undergoing transplantation","volume":"377","author":"Jordan","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2023.150779_bib0108","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.tmrv.2022.05.003","article-title":"Chop-chop: the future of bacterial enzymes in transfusion medicine","volume":"36","author":"Klontz","year":"2022","journal-title":"Trans Med Rev"},{"key":"10.1016\/j.tmrv.2023.150779_bib0109","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1038\/s41467-023-38453-1","article-title":"Mechanism of glycoform specificity and in vivo protection by an anti-afucosylated IgG nanobody","volume":"14","author":"Gupta","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.tmrv.2023.150779_bib0110","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/trf.16309","article-title":"Could antigen loss be a potential mechanism to explain antibody-mediated immune suppression?","volume":"61","author":"Cruz-Leal","year":"2021","journal-title":"Transfusion"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088779632300069X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088779632300069X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:21:23Z","timestamp":1760138483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088779632300069X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":110,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S088779632300069X"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2023.150779","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current Insights Into K-associated Fetal Anemia and Potential Treatment Strategies for Sensitized Pregnancies","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2023.150779","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"150779"}}